E-LIB Suche - Ergebnisse für: Morlat, P

1

A Randomized Placebo-Controlled Efficacy Study of a Prime B..:

Lévy, Y. ; Lacabaratz, C. ; Lhomme, E....
Journal of Virology. 95 (2021) 9 - p. , 2021

Link: https://doi.org/10.1128/..

2

Cover Image:

Marcellin, F. ; Morlat, P. ; Wittkop, L...
Journal of Viral Hepatitis. 25 (2018) 3 - p. , 2018

Link: https://doi.org/10.1111/..

3

Protective effect of cannabis and coffee consumption on HCV..:

Protopopescu, C. ; Santos, M.E. ; Sogni, P....
Journal of Hepatology. 68 (2018) - p. S142-S143 , 2018

Link: https://doi.org/10.1016/..

4

Efficacy, safety and patient‐reported outcomes of ledipasvi..:

Rosenthal, E ; Fougerou‐Leurent, C ; Renault, A...
HIV Medicine. 19 (2017) 3 - p. 227-237 , 2017

Link: https://doi.org/10.1111/..

5

Impaired patient‐reported outcomes persist in HIV‐HCV co‐in..:

Marcellin, F. ; Morlat, P. ; Wittkop, L...
Journal of Viral Hepatitis. 25 (2017) 3 - p. 314-315 , 2017

Link: https://doi.org/10.1111/..

6

Cytochrome 2B6 polymorphism and efavirenz‐induced central n..:

Gallien, S ; Journot, V ; Loriot, M‐A...
HIV Medicine. 18 (2017) 8 - p. 537-545 , 2017

Link: https://doi.org/10.1111/..

7

Reference curves for CD4 T‐cell count response to combinati..:

Bouteloup, V ; Sabin, C ; Mocroft, A...
HIV Medicine. 18 (2016) 1 - p. 33-44 , 2016

Link: https://doi.org/10.1111/..

8

51 HIV patients and caregivers viewpoints towards participa..:

Protière, C. ; Lambotte, O. ; Mora, M....
Journal of Virus Eradication. 2 (2016) - p. 27 , 2016

Link: https://doi.org/10.1016/..

9

Ledipasvir/Sofosbuvir in NS3/4A Protease Inhibitor-Experien..:

Rosenthal, E. ; Fougerou-Leurent, C. ; Renault, A....
Journal of Hepatology. 64 (2016) 2 - p. S764 , 2016

Link: https://doi.org/10.1016/..

10

Psychiatric and substance use disorders in HIV/hepatitis C ..:

Michel, L ; Lions, C ; Winnock, M...
HIV Medicine. 17 (2016) 10 - p. 758-765 , 2016

Link: https://doi.org/10.1111/..

11

Proper use of carbapenems: Role of the infectious disease s..:

Issa, N. ; Pedeboscq, S. ; Le Quellec, F....
Médecine et Maladies Infectieuses. 46 (2016) 1 - p. 10-13 , 2016

Link: https://doi.org/10.1016/..

12

HCV viral load at baseline and at week 4 of telaprevir/boce..:

Salmon, D. ; Bani-Sadr, F. ; Gilbert, C....
Journal of Clinical Virology. 73 (2015) - p. 32-35 , 2015

Link: https://doi.org/10.1016/..

13

LP20 : Safety and efficacy of all-oral daa regimens in HIV-..:

Sogni, P. ; Gilbert, C. ; Lacombe, K....
Journal of Hepatology. 62 (2015) - p. S273-S274 , 2015

Link: https://doi.org/10.1016/..

14

Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Fa..:

Cotte, L. ; Braun, J. ; Lascoux-Combe, C....
Clinical Infectious Diseases. 59 (2014) 12 - p. 1768-1776 , 2014

Link: https://doi.org/10.1093/..

15

Comment on: Antiretroviral treatment French guidelines 2013..:

Morlat, P. ; Hoen, B. ; Blanc, A....
Journal of Antimicrobial Chemotherapy. 69 (2014) 10 - p. 2881-2882 , 2014

Link: https://doi.org/10.1093/..